岳学田教授
岳学田 博士，教授， 博士生导师，山东大学齐鲁青年学者。2012年，博士毕业于山东大学医学院。2018年，入职山东大学基础医学院，加入山东大学免疫与肝脏疾病研究团队（马春红团队 ：https://faculty.sdu.edu.cn/malab/zh_CN/index.htm）进行肝脏相关疾病的研究工作。以第一或通讯作者在Gastroenterology、Genes & Deveolopment、Elife、Cell Death and Differentiation、Redox Biology等顶级期刊发表研究论文，累积发表SCI论文50多篇, 累积引用超过2500次。主持国自然面上项目2项和... More+
- [1] 武专昌. cccDNA Surrogate MC-HBV-Based Screen Identifies Cohesin Complex as a Novel HBV Restriction Factor.. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 14, 1177-1198, 2022.
- [2] 李若文. P4HA2 promotes the progression of papillary thyroid cancer by enhancing degradation of IκBα to activate NF-κB signaling pathway. Cancer cell international, 25, 2025.
- [3] 张召英. Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. SCIENCE IMMUNOLOGY, 9, 2024.
- [4] 任彩月. DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication. Advanced Science, 2024.
- [5] 孙敏. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling. Cell Death & Disease, 15, 2024.
- [6] . Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity. Advanced Science, 2024.
- [7] . Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models. SCIENCE TRANSLATIONAL MEDICINE, 15, 2023.
- [8] 张言坤. ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury. NATURE COMMUNICATIONS, 14, 2023.
- [9] Kong, Youzi. Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation. Redox Biology, 63, 2023.
- [10] 王晓静. 齐鲁医学院研究生细胞生物学教学改革探索. 基础医学教育, 2021.
- [11] 张晓东. TIPE1 promotes liver regeneration by enhancing ROS-FoxO1 axis mediated autophagy.. FEBS JOURNAL, 2022.
- [12] 丁璐. Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6. iScience, 26, 106871, 2023.
- [13] 王玉珍. TIM-4 orchestrates mitochondrial homeostasis to promote lung cancer progression via ANXA2/PI3K/AKT/OPA1 axis. Cell Death & Disease, 14, 2023.
- [14] 焦德雁. Lipid accumulation-mediated histone hypoacetylation drives persistent NK cell dysfunction in anti-tumor immunity. Cell Reports, 42, 2023.
- [15] 王樱淳. Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages. cell reports, 2022.
- [16] 岳学田. SREBF2-STARD4 axis confers sorafenib resistance in HCC by regulating mitochondrial cholesterol homeostasis.. CANCER SCIENCE, 2022.
- [17] 逯景辉. Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma. FRONTIERS IN ONCOLOGY, 11, 2021.
- [18] 张言坤. ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14. CANCER CELL INTERNATIONAL, 22, 2022.
- [19] ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p. Journal of Pathology, 2020.
- [20] Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake. Cell Death and Differentiation, 2020.